(BUSINESS WIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced the appointment of Dr. Steven R. Cohen, a globally recognized leader in plastic and craniofacial surgery, as Medical Strategy Advisor. His appointment marks a significant step in the company’s strategy to expand its global footprint and enhance its medical excellence.
Dr. Cohen is the Founder of Faces+, an advanced aesthetic and reconstructive surgery center in San Diego, California. With over 30 years of clinical experience, he is widely known for his pioneering work in regenerative aesthetics, including the clinical application of fat-derived stem cells, skeletal facial aesthetic surgery, and the integration of artificial intelligence into medical innovation. Dr. Cohen is also the inventor of the internal craniofacial distraction device and LipoCube, both of which have become global standards in the field.
Recognized by Newsweek as one of “America’s Best Plastic Surgeons,” Dr. Cohen has authored numerous scientific publications and textbooks and is a sought-after speaker at international conferences. He is also a Clinical Professor at the University of California, San Diego, and an active member of several global societies, including the American Society of Plastic Surgeons (ASPS).
Following its Nasdaq listing in September 2024, SBC Medical has accelerated its global growth initiatives. With Dr. Cohen’s participation, the company aims to elevate its medical quality, strengthen brand positioning in international markets, expand academic collaborations, and enhance its physician training programs—further solidifying its presence as a truly global medical group.
Message from Yoshiyuki Aikawa, CEO of SBC Medical
“It is a great honor to welcome Dr. Steven R. Cohen, a world-class clinician, to our team. His deep expertise and global perspective will play a transformative role in elevating our medical standards, physician education, and brand development. We look forward to his contributions as we enter a new phase of growth.”
Message from Dr. Steven R. Cohen
“I am honored to join SBC Medical, a company that is not only expanding rapidly but also committed to innovation and patient-centered care. SBC Medical’s investment in physician education and international collaboration resonates deeply with my own values. I look forward to contributing to the advancement of safer, scientifically grounded, and aesthetically refined regenerative aesthetics on a global scale.”
About Dr. Steven R. Cohen (Partial Profile)
Board-certified in Plastic Surgery and Craniofacial Surgery
Founder and Medical Director, Faces+ (San Diego, California)
Clinical Professor of Plastic Surgery, University of California, San Diego
Inventor of the internal craniofacial distraction device and LipoCube
Recognized as one of America’s Best Plastic Surgeons by Newsweek
Global authority in facial reconstruction, stem cell therapy, and 3D surgical simulation
Frequent keynote speaker at international academic societies; author of multiple books and peer-reviewed articles
For more information about Dr. Steven R. Cohen, please visit: https://www.facesplus.com/about/dr-steven-r-cohen/
About SBC Medical
SBC Medical, headquartered in Irvine, California and Tokyo, Japan, owns and provides management services and products to cosmetic treatment centers. The Company is primarily focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale), the provision of cosmetic products to franchisee clinics for resale to clinic customers, licensing of the use of patent-pending and non-patented medical technologies, trademark and brand use, IT software solutions (including but not limited to remote medical consultations), management of the franchisee clinic’s customer rewards program (customer loyalty point program), and payment tools for the franchisee clinics.
For more information, visit https://sbc-holdings.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250714547888/en/
SBC Medical Group Holdings Incorporated (Asia)
Hikaru Fukui / Head of Investor Relations E-mail: ir@sbc-holdings.com
Daisuke Murakami / Public Relations E-mail: pr@sbc.or.jp
ICR LLC (In the US)
Bill Zima / Managing Partner Email: bill.zima@icrinc.com
